What Makes Catalyst (CPRX) a Good Fit for 'Trend Investing'

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for profitable short-term investing, highlighting the utility of a "Recent Price Strength" screen to identify stocks with strong fundamentals that can maintain upward momentum [1]. Group 1: Stock Performance - Catalyst Pharmaceutical (CPRX) has shown a solid price increase of 20.8% over the past 12 weeks, indicating investor confidence in its potential upside [2]. - The stock has also maintained a price increase of 2.2% over the last four weeks, suggesting that the upward trend is still intact [2]. - CPRX is currently trading at 93.9% of its 52-week High-Low Range, indicating it may be on the verge of a breakout [2]. Group 2: Fundamental Strength - CPRX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, which are critical for near-term price movements [3]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [3]. Group 3: Investment Strategy - The article suggests that CPRX may not experience a trend reversal soon, and encourages investors to explore other stocks that meet the "Recent Price Strength" criteria [4]. - It mentions the availability of over 45 Zacks Premium Screens tailored to different investing styles, which can help identify potential winning stocks [4]. - The Zacks Research Wizard is highlighted as a tool for backtesting stock-picking strategies, enhancing the likelihood of profitable results [4].